Diabetes is a global health threat.
Advanced therapy medicines: towards increased development and patient access
The European Medicines Agency (EMA) has published today a set of ideas to better support development and expand patients’ access to high quality, safe and effective advanced therapy medicinal products (ATMPs).
€1 Million was awarded to Minicare HNL, the winner of the Horizon Prize 'Better use of antibiotics'
On 6 February 2017, Carlos Moedas, EU Commissioner for Research, Science and Innovation, awarded a €1 million Prize to Minicare HNL , for a finger prick test that can diagnose in less than ten minutes a bacterial infection and identify if a patient can be treated safely without antibiotics.
Register for the 3rd IRDiRC Conference in Paris, France
The 3rd International Rare Diseases Research Consortium (IRDiRC) Conference, will be held on February 8-9, 2017, in Paris, France.
All stakeholders – investigators, policy makers, opinion leaders, critical thinkers, young researchers, patient advocates and industry members alike – active in the area of rare diseases from across the globe are invited to celebrate achievements in the field, identify future milestones and goals, and work toward bringing diagnoses and therapies to all rare disease patients.
International Conference on Poverty-related and Neglected Diseases
Directorate General Research and Innovation, research funders, academia and policy makers gather tomorrow to discuss the conclusions and recommendations of the study on Poverty-related and Neglected Diseases (PRND). The study aimed to evaluate the role of EU research on PRND in contributing to achieving universal health coverage and improving population health in low and middle–income countries.
Study of volunteer blood donors in Martinique provides new information about Zika virus infection
A large study of volunteer blood donors has been performed in Martinique Island during the local Zika outbreak in 2016 by Pierre Gallian and collaborators. The research team is part of ZIKAlliance, a project funded by the European Union Horizon 2020 Research and Innovation Programme to better understand the clinical and fundamental aspects of infections by Zika virus.
Coalition for Epidemic Preparedness Innovation launched at the WEF Annual Meeting 2017
Launched today at the World Economic Forum (WEF) Annual Meeting in Davos was of the Coalition of Epidemic Preparedness Innovation (CEPI) – a global non-profit public-private partnership founded by the Government of Norway, the Government of India, the Bill & Melinda Gates Foundation, the Wellcome Trust and the WEF. The European Commission will contribute to CEPI's overall objectives in the area of epidemic preparedness, which are in line with that of the European Commission, and plans to co-fund actions with CEPI, such as through the Innovative Medicines Initiative.
- The Lancet
- The New England Journal of Medicine
- Wellcome Trust Press Release
- Watch: Let's #OutsmartEpidemics
European Medicines Agency – 2016 highlights for human medicines
EMA has published an overview of its key recommendations of 2016 in relation to the marketing authorisations of new medicines and the safety monitoring of authorised medicines.
20-22 February 2017, Berlin, Germany - World ADC Berlin
21-22 February 2017, London, United Kingdom - CommBeBiz: Bioeconomy Impact 2017 - The Journey to Innovation